Aug 13, 2007 - Medtronic Inc. has entered into a definitive agreement with Biophan Technologies Inc. to acquire its MRI safety patents in a transaction worth $11 million in cash, as part of Medtronic’s strategy to develop solutions for the contraindication between pacemakers and MRI machines.

Under the terms of the agreement, Biophan will transfer to Medtronic its MRI safety patent portfolio, which includes technologies that make medical devices, such as pacemakers, safe for use with MRI.

Aug. 9, 2007 - Abiomed Inc. today announced financial results for its first quarter of fiscal 2008 with record revenue of $14.1 million, representing growth of 8 percent over a strong first quarter of fiscal 2007, which was up 55 percent over the first quarter of fiscal 2006.

Recent financial and operating highlights include:

- Record revenue of $14.1 million, which represents the highest quarterly revenue in Company history.

- Record total Impella revenue, up 157 percent and record Impella Console revenue.

August 9, 2007 - Compared with their counterparts a decade ago, today's heart attack patients are receiving emergency angioplasty or clot-busting drugs to re-open clogged arteries at a far greater rate, but 10 percent of patients who could benefit from this life-saving treatment still do not receive it, according to a study published in The American Journal of Medicine by Yale and University of Mi

August 8, 2007 - Orbotech Ltd. announced that it has signed a definitive agreement to acquire 3D - Danish Diagnostic Development A/S (DDD), a privately-held Danish company that develops and manufactures gamma cameras for nuclear medicine, as part of a strategy to generate a projected $30 million in annual revenues, which is expected to be immediately accretive to Orbotech on a non-GAAP basis.

August 8, 2007 - A U.S. District Court judge enforced a settlement this week between Abbott Laboratories Inc. and Israeli company Medinol Ltd. to removed an entanglement for a key drug-eludting stent heart device Abbott is bringing to the United States.

August, 8, 2007 - The Medicines Company announced that the new guidelines released yesterday by the American College of cardiology (ACC) and the American Heart Association (AHA) grant a Class I (level of evidence B) recommendation that Angiomax "should be administered" as one of the choices for anticoagulant therapy for patients with unstable angina (UA) and non-ST-elevated myocardial infarction (NSTEMI) who are selected to receive an invasive strategy.

August 8, 2007 - CircuLite Inc. reported the launch of the clinical development program for its Synergy Pocket Circulatory Assist Device with the successful implantation of the first patient in a European feasibility trial, synergy is a miniature implantable blood pump, the size of a AA battery, that can be implanted superficially in a pocket, like a pacemaker.

August 8, 2007 – The FDA gave ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, clearance to market and sell the ZOLL AED Pro with See-Thru CPR technology, which is designed to help minimize interruptions in CPR, as ZOLL aims to comply with one of the key recommendations of the American Heart Association's (AHA) Guidelines for Advanced Cardiac Life Support.

August 8, 2007 – Emageon Inc. reported financial results for its second quarter ended June 30, 2007, reflecting net positive operating cash flow of $3.7 million for the second quarter of 2007, an improvement of $7.7 million over net negative operating cash flow of $4.0 million in first quarter 2007. For the six months ended June 30, 2007, net cash used in operations was $0.3 million. At June 30, 2007, cash and marketable securities totaled $20.9 million, compared to $23.0 million at December 31, 2006.

August 7, 2007 - The American College of Cardiology and the American Heart Association have jointly released revised Guidelines for the Management of Patients with Unstable Angina (UA)/Non-ST- Elevation Myocardial Infarction (NSTEMI).

Subscribe Now